Clinical trial
Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients (Trigon)
The purpose of this study is to evaluate the efficacy and safety of CHF 5259 (glycopyrrolate bromide) for the treatment of COPD patients.
| Category | Value |
|---|---|
| Study start date | 2014-07-02 |